107 related articles for article (PubMed ID: 26423666)
1. Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma.
Wang P; He Y; Ma X; Sun B; Huang B; Zhu C; Liu Y
Med Sci Monit; 2015 Oct; 21():2943-9. PubMed ID: 26423666
[TBL] [Abstract][Full Text] [Related]
2. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
Wang X; Zhang J; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.
Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K
Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663
[TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
[TBL] [Abstract][Full Text] [Related]
5. Down stream involvement of the bile duct in hepatolithiasis.
Lu S; Yan L; Rao L; Xia T; Gou J; Zhang S; Lei S
Chin Med J (Engl); 2002 Jan; 115(1):62-4. PubMed ID: 11930661
[TBL] [Abstract][Full Text] [Related]
6. Silver-binding nucleolar organizer regions in hepatolithiasis and bile duct cancer.
Ker CG
Proc Natl Sci Counc Repub China B; 1997 Apr; 21(2):43-8. PubMed ID: 9276966
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
9. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of basement membrane type IV collagen α2 and α6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma.
Hirashima K; Iyama K; Baba Y; Honda Y; Sado Y; Ninomiya Y; Watanabe M; Takamori H; Beppu T; Baba H
J Surg Oncol; 2013 Mar; 107(4):402-7. PubMed ID: 22927259
[TBL] [Abstract][Full Text] [Related]
11. EGFR, COX2, p-AKT expression and PIK3CA mutation in distal extrahepatic bile duct carcinoma.
Moon A; Chin S; Kim HK; Kwak JJ; Koh ES; Kim YW; Jang KT
Pathology; 2016 Jan; 48(1):35-40. PubMed ID: 27020207
[TBL] [Abstract][Full Text] [Related]
12. Elevation of carcinoembryonic antigen related to biliary malignancy in hepatolithiasis.
Ker CG; Sheen PC; Chien CH; Wu CC
Surg Today; 1993; 23(6):496-9. PubMed ID: 8358193
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
Choi HJ; Kim HJ; Choi JH
Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M
Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358
[TBL] [Abstract][Full Text] [Related]
15. A study of CEA, CA 19-9 and CA 125 in biliary tract diseases.
Ker CG; Wu CC; Chen JS; Hou MF; Lee KT; Sheen PC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Feb; 5(2):107-13. PubMed ID: 2733069
[TBL] [Abstract][Full Text] [Related]
16. [Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma].
Kim HJ; Kim JS; Kang CD; Lee SJ; Kim JY; Yeon JE; Park JJ; Shim JJ; Byun KS; Bak YT; Lee CH
Korean J Gastroenterol; 2005 Jan; 45(1):52-9. PubMed ID: 15665568
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis.
Kim HJ; Lee KT; Kim EK; Sohn TS; Heo JS; Choi SH; Choi DI; Lee JK; Paik SW; Rhee JC
J Gastroenterol Hepatol; 2004 May; 19(5):582-8. PubMed ID: 15086604
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
Zheng J; Zhu YM
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]